Jan 9 2024 |
5th Circuit Issues Blistering Critique of FDA’s Handling of PMTAs for E-Cigarettes |
Keller and Heckman LLP |
Jan 9 2024 |
CORE Releases 2022 Annual Outbreak Report |
Keller and Heckman LLP |
Jan 9 2024 |
Malta Initiative Survey on OECD Test Guidelines and Guidance Documents Will Close January 12 |
Bergeson & Campbell, P.C. |
Jan 9 2024 |
Blazing Trails: Exploring ESOPs in the Cannabis Industry |
Bradley Arant Boult Cummings LLP |
Jan 8 2024 |
Gold Dome Report – Legislative Day 1 (2024) |
Nelson Mullins |
Jan 8 2024 |
HHS, ONC HTI-1 Final Rule Introduces New Transparency Requirements for Artificial Intelligence in Certified Health IT |
Mintz |
Jan 8 2024 |
Extended Producer Responsibility for Packaging: What’s Ahead in 2024 |
Hunton Andrews Kurth |
Jan 5 2024 |
Trending in Telehealth: December 21, 2023 – January 3, 2024 |
McDermott Will & Emery |
Jan 5 2024 |
Texas Urges Federal Court to Toss Tofurky Challenge of Labeling Law |
Keller and Heckman LLP |
Jan 5 2024 |
McDermottPlus Check-Up: January 5, 2024 |
McDermott Will & Emery |
Jan 5 2024 |
Hospital and MA Plan Considerations for CMS Final Rule to Remedy 340B Drug Payment Policy |
Epstein Becker & Green, P.C. |
Jan 4 2024 |
With Increased New York Minimum Wage Come Modified Obligations Under State Wage Orders |
Jackson Lewis P.C. |
Jan 4 2024 |
2023: A Good Trip Around the Sun for Psychedelics |
Bradley Arant Boult Cummings LLP |
Jan 4 2024 |
Not So Fast My Friend: Alabama Medical Commission Halts Issuance of Integrated (and Probably Dispensary) Licenses |
Bradley Arant Boult Cummings LLP |
Jan 4 2024 |
Brand Selection Primer for Emerging Healthy F&B Companies |
Foley & Lardner LLP |
Jan 4 2024 |
FDA Announces Availability of Cosmetics Direct Portal and Publication of Final Guidance on Cosmetic Facility Registration and Product Listing |
ArentFox Schiff LLP |
Jan 4 2024 |
Acetaminophen MDL: Judge Excludes All of Plaintiffs’ Causation Experts Pursuant to Newly-Amended FRE Rule 702 |
Foley & Lardner LLP |
Jan 4 2024 |
Espresso Yourself: When Prosecution History as a Whole Doesn’t Demonstrate Clear, Unmistakable Disclaimer |
McDermott Will & Emery |
Jan 4 2024 |
Same Applicant, Similar Claims Support Obviousness-Type Double Patenting Rejection |
McDermott Will & Emery |
Jan 3 2024 |
NIOSH Reviews Past Nanotechnology Guidance and Needs for Future Research |
Bergeson & Campbell, P.C. |
Jan 3 2024 |
DOT Random Drug and Alcohol Testing Rates for 2024 |
Jackson Lewis P.C. |
Jan 3 2024 |
Defending Psychedelics: Congress Includes Psychedelic Provisions in Defense Authorization Act |
Bradley Arant Boult Cummings LLP |
Jan 3 2024 |
Federal Circuit Clarifies Reach of “Artificial” Act of Patent Infringement |
Proskauer Rose LLP |
Jan 3 2024 |
Unpacking Averages: The Seasonality of FDA 510(k) Decision-Making and the Impact of Michigan Playing for a National Championship |
Epstein Becker & Green, P.C. |
Jan 3 2024 |
FDA Supplements Response to D-Tagatose Petition |
Keller and Heckman LLP |
Jan 3 2024 |
FDA Issues Guidance on Reformulating Drug Products that Contain Carbomers Manufactured with Benzene |
Keller and Heckman LLP |
Jan 3 2024 |
APHIS Reopens Comment Period on Proposed Additional Exemptions for Plants Modified or Produced Through Genetic Engineering |
Bergeson & Campbell, P.C. |
Jan 2 2024 |
New U.S. Action Against Wine Bottle Imports |
Squire Patton Boggs (US) LLP |
Jan 2 2024 |
US State Law Roundup – 2023 Year-end Update |
Squire Patton Boggs (US) LLP |
Jan 2 2024 |
The Intertwining Nature of Motivation to Combine and Reasonable Expectation of Success |
Sheppard, Mullin, Richter & Hampton LLP |
Jan 2 2024 |
Looking Back and Moving Forward: MoCRA Regulatory Developments Ring in the New Year |
Mintz |
Jan 2 2024 |
Prop 12 Takes Full Effect in California |
Keller and Heckman LLP |
Dec 29 2023 |
OSTP Publishes Report on Vision, Needs, and Proposed Actions for Data for the Bioeconomy Initiative |
Bergeson & Campbell, P.C. |
Dec 29 2023 |
EPA Registers Novel Pesticide Technology for Potato Crops |
Bergeson & Campbell, P.C. |
Dec 28 2023 |
Two-Dimensional Barcodes: How 2D Could Change Retail |
Foley & Lardner LLP |
Dec 27 2023 |
NNI Publishes Economic Impact Analysis of 20 Years of Nanotechnology Investments |
Bergeson & Campbell, P.C. |
Dec 27 2023 |
Postal ServiceTM Proposes New Mailing Standards for Hazardous Materials Outer Packaging and Nonregulated Toxic Materials |
Bergeson & Campbell, P.C. |
Dec 26 2023 |
CMS Issues Revised Guidance Implementing Medicare Inflation Rebates Under the Inflation Reduction Act |
ArentFox Schiff LLP |
Dec 23 2023 |
China’s National Intellectual Property Administration to Allow Third-Party Challenges to Pharmaceutical Patent Term Extensions |
Schwegman, Lundberg & Woessner, P.A. |
Dec 22 2023 |
Private Investors and Digital Health Attracting OIG Attention: General Compliance Program Guidance to Watch |
McDermott Will & Emery |
Dec 22 2023 |
Medicare Provider and Supplier Enrollment Requirements: Program Integrity Changes for 2024 |
McDermott Will & Emery |
Dec 21 2023 |
China’s State Council Releases Amended Implementing Regulations of the Patent Law |
Schwegman, Lundberg & Woessner, P.A. |
Dec 21 2023 |
Pharmaceutical Companies Have Rights if the Federal Government Seized their Patents |
Sheppard, Mullin, Richter & Hampton LLP |
Dec 21 2023 |
Inherent Limitations in Prior Patents can Lead to Obviousness-Type Double-Patenting |
Mintz |
Dec 21 2023 |
FDA Announces Updated Instructions for Serious Adverse Event Reporting for Cosmetic Products |
ArentFox Schiff LLP |
Dec 21 2023 |
FSA Assesses Oyster Import Risks |
Keller and Heckman LLP |
Dec 21 2023 |
APHIS Extends Comment Period on Proposed Exemptions for Genetically Modified Plants |
Keller and Heckman LLP |
Dec 21 2023 |
Australia and New Zealand Consult on the First Cell-Cultured Meat Application |
Keller and Heckman LLP |
Dec 20 2023 |
2023: Another Year Chock Full of Challenges for FDA |
Mintz |
Dec 20 2023 |
Boosting Biotech: New York City Revives Tax Credits for Emerging Companies |
Mintz |